Jove
Visualize
Contact Us

Related Concept Videos

Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

1.7K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.7K
Internal Receptors01:31

Internal Receptors

74.8K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.8K
Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

111.6K
Overview
111.6K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

86.8K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.8K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

132.2K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
132.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A systematic review of qualitative research exploring resilience in Academia.

International journal of qualitative studies on health and well-being·2026
Same author

Assessing the accuracy of routing engines in replicating children's walking routes to school: a comparative study of google, mapbox, and OSRM.

International journal of health geographics·2026
Same author

Communicating health messages to children and families in primary care: a mixed-methods study in Aotearoa New Zealand.

Journal of primary health care·2026
Same author

AI Guided Parenteral Nutrition Therapy After Hematopoietic Stem Cell Transplantation.

NPJ digital medicine·2026
Same author

Post CAR-T Measurable Residual Disease Monitoring in Mantle Cell Lymphoma Enables Early Detection of Disease Relapse.

American journal of hematology·2026
Same author

Respiratory Viral Infections Following CD19 CAR T-Cell Therapy.

Journal of medical virology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 15, 2026

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

2.5K

Posttransplant chimeric antigen receptor therapy.

Melody Smith1, Johannes Zakrzewski1, Scott James1

  • 1Center for Cell Engineering and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.

Blood
|January 24, 2018
PubMed
Summary
This summary is machine-generated.

Chimeric antigen receptor (CAR) T-cell therapy shows promise for blood cancers. Researchers are exploring ways to use donor CAR T-cells safely, aiming to prevent graft-versus-host disease for better patient outcomes.

More Related Videos

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

836
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.8K

Related Experiment Videos

Last Updated: Feb 15, 2026

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

2.5K
Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

836
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.8K

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Chimeric antigen receptor (CAR) T-cell therapy is a leading treatment for refractory hematological malignancies.
  • CD19-targeted CAR T-cells have achieved significant success in B-cell leukemias and lymphomas using autologous (patient's own) T-cells.

Purpose of the Study:

  • To review strategies for utilizing allogeneic (donor) CAR T-cells for treating relapsed hematological malignancies post-hematopoietic stem cell transplantation.
  • To discuss methods for mitigating graft-versus-host disease (GVHD) risks associated with allogeneic CAR T-cell therapies.

Main Methods:

  • Review of current literature on CAR T-cell therapy, focusing on allogeneic approaches.
  • Examination of techniques to prevent or reduce alloreactivity and GVHD, including T-cell receptor (TCR)-deficient cells and regulatory T-cells.

Main Results:

  • Autologous CD19 CAR T-cells have demonstrated high remission rates in various B-cell malignancies.
  • Allogeneic CAR T-cells offer a potential treatment for relapse after stem cell transplantation but face challenges with alloreactivity.

Conclusions:

  • Advances in CAR design, T-cell selection, and gene editing are crucial for the safe application of allogeneic CAR T-cells.
  • Developing GVHD-free allogeneic CAR T-cell therapies is a key goal for expanding treatment options in hematological cancers.